Neurogene Grants Stock Options to New Employees Under 2025 Inducement Plan
Neurogene Inc. has granted non-qualified stock options to two new employees, allowing them to purchase a total of 4,860 shares of the company's common stock. These options will vest over four years, with 25% vesting on the first anniversary and the remainder vesting monthly over the next three years, contingent on continued employment.
Neurogene Inc. has approved the grant of non-qualified stock options to purchase a total of 4,860 shares of the company’s common stock for two new employees. These options have an exercise price equal to the closing price of Neurogene’s shares on the grant date and will vest over four years: 25 percent will vest on the first anniversary of the vesting commencement date, with the remaining shares vesting in equal monthly installments over the following three years, contingent on continued employment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurogene Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251204721853) on December 04, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
